Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening.

Autor: Glennon KI; Department of Human Genetics, McGill University, Montreal, Canada.; Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Canada.; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Endo M; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Usui Y; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Iwasaki Y; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Breau RH; University of Ottawa, Ottawa, Canada., Kapoor A; Juravinski Cancer Centre, McMaster University, Hamilton, Canada.; Deceased., Lathrop M; Department of Human Genetics, McGill University, Montreal, Canada.; Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Canada., Tanguay S; Department of Surgery, Division of Urology, McGill University, Montreal, Canada., Momozawa Y; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Riazalhosseini Y; Department of Human Genetics, McGill University, Montreal, Canada.; Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Canada.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2400094.

Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma.

Autor: Vasudev NS; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, United Kingdom., Scelo G; World Health Organisation (WHO), International Agency for Research on Cancer (IARC), The Genomic Epidemiology Branch, Lyon, France., Glennon KI; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montreal, Québec, Canada., Wilson M; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, United Kingdom., Letourneau L; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada., Eveleigh R; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada., Nourbehesht N; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montreal, Québec, Canada., Arseneault M; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada., Paccard A; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada., Egevad L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Viksna J; Institute of Mathematics and Computer Science, University of Latvia, Riga, Latvia., Celms E; Institute of Mathematics and Computer Science, University of Latvia, Riga, Latvia., Jackson SM; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, United Kingdom., Abedi-Ardekani B; World Health Organisation (WHO), International Agency for Research on Cancer (IARC), The Genomic Epidemiology Branch, Lyon, France., Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, United Kingdom., Selby PJ; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, United Kingdom., Trainor S; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, United Kingdom., Kimuli M; Pyrah Department of Urology, Leeds Teaching Hospitals NHS Trust, Lincoln Wing, St James's University Hospital, Leeds, United Kingdom., Cartledge J; Pyrah Department of Urology, Leeds Teaching Hospitals NHS Trust, Lincoln Wing, St James's University Hospital, Leeds, United Kingdom., Soomro N; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Adeyoju A; Stockport NHS Foundation Trust, Stockport, United Kingdom., Patel PM; Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Wozniak MB; World Health Organisation (WHO), International Agency for Research on Cancer (IARC), The Genomic Epidemiology Branch, Lyon, France., Holcatova I; Charles University in Prague, First Faculty of Medicine, Institute of Hygiene and Epidemiology, Prague, Czech Republic., Brisuda A; University Hospital Motol, Prague, Czech Republic., Janout V; Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic., Chanudet E; World Health Organisation (WHO), International Agency for Research on Cancer (IARC), The Genomic Epidemiology Branch, Lyon, France., Zaridze D; N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russian Federation., Moukeria A; N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russian Federation., Shangina O; N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russian Federation., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Navratilova M; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Mates D; National Institute of Public Health, Bucuresti, Romania., Jinga V; Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania., Bogdanovic L; Institute of Pathology, School of Medicine Belgrade, University of Belgrade, Belgrade, Serbia., Kovacevic B; Institute of Pathology and Forensic Medicine, Military Medical Academy, Belgrade, Serbia., Cambon-Thomsen A; Institut National de la Santé et de la Recherche Médicale (INSERM) and Université Toulouse III Paul Sabatier (UPS), Toulouse, France., Bourque G; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montreal, Québec, Canada., Brazma A; European Bioinformatics Institute, European Molecular Biology Laboratory, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, United Kingdom., Tost J; Centre National de Recherche en Génomique Humaine, CEA - Institut de Biologie Francois Jacob, University Paris Saclay, Evry, France., Brennan P; World Health Organisation (WHO), International Agency for Research on Cancer (IARC), The Genomic Epidemiology Branch, Lyon, France., Lathrop M; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montreal, Québec, Canada., Riazalhosseini Y; Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montreal, Québec, Canada., Banks RE; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, United Kingdom.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 03; Vol. 29 (7), pp. 1220-1231.

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma.

Autor: Glennon KI; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada.; Department of Human Genetics, McGill University, 1205 Doctor Penfield Avenue, Montreal, QC H3A 1B1, Canada., Maralani M; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada.; Department of Human Genetics, McGill University, 1205 Doctor Penfield Avenue, Montreal, QC H3A 1B1, Canada.; The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Abdian N; The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Paccard A; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada., Montermini L; The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Nam AJ; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada., Arseneault M; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada., Staffa A; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada., Jandaghi P; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada.; Department of Human Genetics, McGill University, 1205 Doctor Penfield Avenue, Montreal, QC H3A 1B1, Canada., Meehan B; The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Brimo F; Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada., Tanguay S; Division of Urology, McGill University, Montreal, QC H4A 3J1, Canada., Rak J; The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Riazalhosseini Y; McGill Genome Centre, McGill University, 740 Doctor Penfield Avenue, Montreal, QC H3A 0G1, Canada.; Department of Human Genetics, McGill University, 1205 Doctor Penfield Avenue, Montreal, QC H3A 1B1, Canada.

Publikováno v: Cancers [Cancers (Basel)] 2021 Nov 20; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 20.